Fast-track eligibility, costs and quality of recovery after intravenous anaesthesia with propofol-remifentanil versus balanced anaesthesia with isoflurane-alfentanil.
D000328:Adult; D015760:Alfentanil / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D000762:Anesthesia Recovery Period; D000771:Anesthesia, Intravenous / Q000009:adverse effects / Q000191:economics / Q000706:statistics & numerical data; D019162:Anesthetics, Combined / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D018685:Anesthetics, Inhalation / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D018686:Anesthetics, Intravenous / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D016527:Drug Costs; D005260:Female; D017048:Health Care Costs; D006801:Humans; D007530:Isoflurane / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D007902:Length of Stay / Q000191:economics / Q000706:statistics & numerical data*; D008297:Male; D013517:Otorhinolaryngologic Surgical Procedures / Q000191:economics / Q000379:methods; D017063:Outcome Assessment, Health Care / Q000191:economics; D010880:Piperidines / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D011183:Postoperative Complications / Q000191:economics / Q000453:epidemiology; D015742:Propofol / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D011997:Recovery Room / Q000191:economics / Q000706:statistics & numerical data*; D000077208:Remifentanil
D019162:Anesthetics, Combined; D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D010880:Piperidines; D015760:Alfentanil; D007530:Isoflurane; D000077208:Remifentanil; D015742:Propofol